MPM BioVentures 2014, L.P.
SEC CIK 1609492 · EDGAR
BoughtSold
Most active insiders at TRDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PARMAR KUSH | Dir, 10% | — | $3.65M |
| 2 | MPM BIOVENTURES 2018, L.P. | 10% | — | $3.60M |
| 3 | MPM BioVentures 2014, L.P. | 10% | — | $3.60M |
| 4 | 5AM Ventures V, L.P. | 10% | — | $3.00M |
| 5 | Baker Bros. Advisors (GP) LLC | 10% | $1.35M | — |
| 6 | WENTWORTH KORY JAMES | CFO | — | $433.6K |
| 7 | Dowden Nathan J | Pres, COO | — | $425.7K |
| 8 | Sethuraman Natarajan | Pres, Research, Develop | — | $398.8K |
| 9 | BAKER FELIX | 10% | $261.8K | — |
| 10 | Zeiher Bernhardt G | Dir | $29.3K | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-09-09 19:23 | 2026-09-04+ | TRDA | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% | S - Sale | $7.33 | -259.8K | 3.89M | -6% | -$1.91M |
| MI | 2026-09-03 19:21 | 2026-09-01+ | TRDA | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% | S - Sale | $7.14 | -86.5K | 4.14M | -2% | -$617.4K |
| MI | 2026-08-31 18:25 | 2026-08-27+ | TRDA | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% | S - Sale | $7.08 | -86.9K | 4.23M | -2% | -$615.8K |
| MI | 2026-08-26 21:28 | 2026-08-24+ | TRDA | Entrada Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% | S - Sale | $7.36 | -62.7K | 4.32M | -1% | -$461.5K |
| MI | 2025-11-12 | 2025-11-07+ | HOWL | Werewolf Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% | S - Sale | $1.13 | -213.5K | 5.84M | -4% | -$241.3K |
Purchase Sale Sale after option exercise All abbreviations